Contingency Management of Alcohol Abuse in the Severely Mentally ILL

Completed · Not applicable

Conditions studied: Alcohol Abuse, Schizophrenia, Bipolar Disorder, Major Depressive Disorder

In brief

The investigators will evaluate the efficacy of a comprehensive 12-week contingency management intervention for treating alcohol dependence for persons with severe mental illness who are seen within the context of a community mental health center setting. The primary contingency will be submission of alcohol-free urines. Additional reinforcers will be provided for intensive outpatient addiction treatment attendance. Reinforcers will be vouchers or actual items useful for day-to-day living. Participants will be 120 adults diagnosed with alcohol dependance and severe mental illness.

Key facts

Study ID

NCT01567943

Run by

University of Washington

People needed

123

Starts

2012-03-01

Expected to finish

2016-02-01

Last updated by the study team

2017-02-23

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Currently receiving psychiatric [AND intensive outpatient addiction treatment] at Community Psychiatric Clinic (CPC).
• Aged 18 to 65 years.
• Ability to understand written and spoken English language.
• DSM-IV diagnosis of alcohol dependence as assessed by the MINI psychiatric interview.
• Diagnosis of current serious mental illness: schizophrenia, schizoaffective disorders, bipolar disorder I or II, or recurring major depressive disorders as assessed by the MINI psychiatric interview.
• Alcohol use in the month prior to study entry: self-reported alcohol use of 5 days or more during the 30 days prior to study entry (5 drinking days/month is selected based on previous research reporting alcohol use in 18% of days assessed in a sample of psychiatric outpatients with co-occurring SUDs \& SMI).120
• A CPC treating clinician must affirm the potential participant is safe to participate in the study.

You may not qualify if…

• A significant risk of dangerous alcohol withdrawal: a history of alcohol detoxification or seizure in the last 12 months AND participant or clinician concern that abstinence will induce dangerous alcohol withdrawal.
• DSM-IV diagnosis of current (last year) drug dependence as assessed by the MINI interview.
• Any medical/psychiatric condition, or severity of that condition, that in the opinion of the PI, would compromise safe study participation.
• Chart defined organic brain disorder or dementia.
• Inability to provide informed consent as measured by the University of California San Diego Brief Assessment of Capacity to Consent (UBACC), a tool designed to screen for ability to provide informed consent for research. If indicated by the UBACC screening process, the more comprehensive MacCAT-CR will be used.

Where it is running

• Harborview Medical Center — Seattle, Washington, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.